Premium
F3‐03‐03: EFFECTS OF VISUAL STIMULI ON DECISION‐MAKING CAPACITY OF PEOPLE WITH DEMENTIA
Author(s) -
Bourgeois Michelle S.
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.2750
Subject(s) - dementia , proxy (statistics) , psychology , cognition , medical decision making , quality of life (healthcare) , clinical psychology , cognitive psychology , developmental psychology , audiology , medicine , disease , psychiatry , family medicine , psychotherapist , computer science , pathology , machine learning
group 1 subjects in the study was 2,112 days and of the group 2 subjects was 2,003 days. We compared anxiolytic medication usage in the 2 study groups. Procedures for these analyses are described in Table 1. Briefly, we considered time off anxiolytics in group 1 as positive, since subjects did not take, or discontinued, anxiolytics, during this period. For group 2, we considered time in which anxiolytics were added as a negative result. We then compared group outcomes. Subsequently, the group blind was broken and the detailed results are shown in Table 1 and summarized below. Results: The difference between the groups in terms of days of anxiolytic medication usage was highly significant (the two-tailed p value < 0.0001), with less usage in subjects randomized to the management program. Conclusions: Since anxiolytic usage is associated with numerous negative outcomes including dependency, seizures upon withdrawal, etc. (see Table 2), the CI-PCM program in this studywas associatedwith an important collateral health benefit in terms of decreasing anxiolytic medication usage by community physicians.